Back
Enanta Pharmaceuticals Stock Price Chart
Sponsored
ENTA
Sponsored
NOW is the time to get in on this trillion-dollar megatrend
Get it here.
Buy
54
ENTA
Enanta Pharmaceuticals
Last Price:
14.57
Seasonality Move:
-5.42%
7 Day Trial
ALL ACCESS PASS
$
7
MarketBeat Alert: Strong sell signal just issued for these 20 stocks
Go here now to get free instant access to all 20 stocks to sell.- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ENTA is experiencing selling pressure, which indicates risk of future bearish movement.
Enanta Pharmaceuticals Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 13.63 | Buy |
20-day SMA: | 14.36 | Buy |
50-day SMA: | 14.86 | Sell |
200-day SMA: | 12.7 | Buy |
8-day EMA: | 14.05 | Buy |
20-day EMA: | 14.23 | Buy |
50-day EMA: | 14.24 | Buy |
200-day EMA: | 16.33 | Sell |
Enanta Pharmaceuticals Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.29 | Sell |
Relative Strength Index (14 RSI): | 51.92 | Buy |
Chaikin Money Flow: | -69466 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (13.22 - 16.32) | Sell |
Bollinger Bands (100): | (10.95 - 15.33) | Buy |
Enanta Pharmaceuticals Technical Analysis
Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | May | |||||||||
23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | 06 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Enanta Pharmaceuticals Stock
Is Enanta Pharmaceuticals Stock a Buy?
- Enanta Pharmaceuticals share price is 14.59 while ENTA 8-day simple moving average is 13.63, which is a Buy signal.
- The stock price of ENTA is 14.59 while Enanta Pharmaceuticals 20-day SMA is 14.36, which makes it a Buy.
- Enanta Pharmaceuticals 50-day simple moving average is 14.86 while ENTA share price is 14.59, making it a Sell technically.
- ENTA stock price is 14.59 and Enanta Pharmaceuticals 200-day simple moving average is 12.70, creating a Buy signal.
ENTA Technical Analysis vs Fundamental Analysis
Buy
54
Enanta Pharmaceuticals (ENTA)
is a Buy
Is Enanta Pharmaceuticals a Buy or a Sell?
-
Enanta Pharmaceuticals stock is rated a Buy
The current Enanta Pharmaceuticals [ENTA] share price is $14.59. The Score for ENTA is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
Enanta Pharmaceuticals Stock Info
Market Cap:
308.67M
Price in USD:
14.59
Share Volume:
107.56K
Enanta Pharmaceuticals 52-Week Range
52-Week High:
36.04
52-Week Low:
8.08
Buy
54
Enanta Pharmaceuticals (ENTA)
is a Buy
Enanta Pharmaceuticals Share Price Forecast
-
What is the Enanta Pharmaceuticals stock price today?
The Enanta Pharmaceuticals stock price is 14.59 USD today. -
Will ENTA stock go up or go down?
Enanta Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Enanta Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Enanta Pharmaceuticals is not overvalued.
Is Enanta Pharmaceuticals Stock a Buy?
- Enanta Pharmaceuticals share price is 14.59 while ENTA 8-day exponential moving average is 14.05, which is a Buy signal.
- The stock price of ENTA is 14.59 while Enanta Pharmaceuticals 20-day EMA is 14.23, which makes it a Buy.
- Enanta Pharmaceuticals 50-day exponential moving average is 14.24 while ENTA share price is 14.59, making it a Buy technically.
- ENTA stock price is 14.59 and Enanta Pharmaceuticals 200-day simple moving average is 16.33, creating a Sell signal.
Fundamental Analysis of Enanta Pharmaceuticals
Is Enanta Pharmaceuticals a good investment?
- Analysts estimate an earnings increase this quarter of $0.31 per share, a decrease next quarter of $0.16 per share, an increase this year of $1.86 per share, and an increase next year of $0.05 per share.
Technical Analysis of Enanta Pharmaceuticals
Should I short Enanta Pharmaceuticals stock?
- ENTA Moving Average Covergence Divergence (MACD) indicator is -0.29, suggesting Enanta Pharmaceuticals is a Sell
- Enanta Pharmaceuticals Relative Strength Index (RSI) is 51.92, which suggest Enanta Pharmaceuticals is overbought
- The Bollinger Bands (25) for Enanta Pharmaceuticals is (13.22 - 16.32), which suggest Enanta Pharmaceuticals is a Buy
- The Bollinger Bands (100) for Enanta Pharmaceuticals is (10.95 - 15.33), which suggest Enanta Pharmaceuticals is a Buy
* Enanta Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.